Leukaemia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with blood cancer receiving TKI treatment:

• People who have been diagnosed with CML (chronic myeloid leukaemia) or CLL (chronic lymphocytic leukaemia)
• People who are due to receive their first dose of a TKI (a type of targeted cancer medication) within the next 30 days, or who received their first dose within the past 30 days
• People who are 18 years of age or older
• People who can speak and read English
• People who are able to understand the study and are willing to sign a consent form

For cancer-free people joining as a comparison group:

• People who are 18 years of age or older
• People who can speak and read English
• People who are able to understand the study and are willing to sign a consent form
• People whose age is within 5 years (older or younger) of a matched participant in the cancer group, and who are the same sex as that participant

Who may not be able to join:

• People who have a history of cancer that has spread to other parts of the body, a primary brain tumour, or radiation treatment to the brain
• People who have previously received TKI therapy at any point
• People who have received certain other cancer treatments — including chemotherapy, immune checkpoint therapy, hormonal therapy, biologic therapy, or radiotherapy — within the past 5 years (note: prior use of hydroxyurea for CML or CLL, or use of obinutuzumab or rituximab alongside TKI therapy for CLL, are exceptions and may still be permitted — confirm with trial site)
• People who have had a stroke within the past year, or who still have ongoing thinking or memory difficulties from a stroke that occurred more than a year ago
• People who have had a head injury with loss of consciousness within the past year
• People who have been diagnosed with dementia or a serious condition affecting the brain and nervous system that impacts daily life
• People who have been hospitalised for a psychiatric condition within the past year
• People who are currently pregnant
• People who report being colour blind
• People who are staff members on this study and have previously seen or administered the cognitive tests being used (such as CANTAB)

Important: Always verify eligibility with the trial site directly before applying.